Form: 10-K

Annual report pursuant to Section 13 and 15(d)

March 18, 2024

 

EXHIBIT 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in Registration Statement Nos. 333-268619 and 333-256850 on Form S-3 and Registration Statement Nos. 333-274917, 333-272103, 333-270742, 333-267192, 333-238571, 333-221552, 333-214846, 333-204055, 333-189985, 333-169067, 333-161642, and 333-125796 on Form S-8 of our report dated March 15, 2024, relating to the financial statements of Abeona Therapeutics Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2023.

 

/s/ DELOITTE & TOUCH LLP

 

Morristown, New Jersey

March 15, 2024